These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8122388)

  • 21. [Hepatitis C virus replication in vitro].
    Santos-López G; Vallejo-Ruiz V; Reyes-Leyva J
    Gac Med Mex; 2007; 143(4):351-2. PubMed ID: 17969846
    [No Abstract]   [Full Text] [Related]  

  • 22. [Adaptive cell immune response against the hepatitis C virus infection].
    Rallón NI; Soriano V; Benito JM
    Med Clin (Barc); 2007 Oct; 129(12):469-76. PubMed ID: 17953913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Entry and replication of recombinant hepatitis C viruses in cell culture.
    Vieyres G; Pietschmann T
    Methods; 2013 Feb; 59(2):233-48. PubMed ID: 23009812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of hepatitis C virus protein epitopes for vaccine development.
    Koshy R; Inchauspé G
    Trends Biotechnol; 1996 Oct; 14(10):364-9. PubMed ID: 8987634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up of hepatitis B virus and hepatitis C virus replicative levels in chronic hepatitis patients coinfected with both viruses.
    Ohkawa K; Hayashi N; Yuki N; Masuzawa M; Kato M; Yamamoto K; Hosotsubo H; Deguchi M; Katayama K; Kasahara A
    J Med Virol; 1995 Jul; 46(3):258-64. PubMed ID: 7561800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiology of hepatitis C virus infection.
    Camps J; Córdoba J; Esteban JI
    Pathol Biol (Paris); 1995 Oct; 43(8):691-702. PubMed ID: 8745591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus replication in patients with occult hepatitis C virus infection.
    Carreño V; Bartolomé J; Castillo I; Quiroga JA
    Hepatology; 2009 Jun; 49(6):2128-9; author reply 2129. PubMed ID: 19475689
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatitis C virus enters human peripheral neuroblastoma cells - evidence for extra-hepatic cells sustaining hepatitis C virus penetration.
    Bürgel B; Friesland M; Koch A; Manns MP; Wedemeyer H; Weissenborn K; Schulz-Schaeffer WJ; Pietschmann T; Steinmann E; Ciesek S
    J Viral Hepat; 2011 Aug; 18(8):562-70. PubMed ID: 20579278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Replication of hepatitis C virus.
    Moradpour D; Penin F; Rice CM
    Nat Rev Microbiol; 2007 Jun; 5(6):453-63. PubMed ID: 17487147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of hepatitis C virus and hepatitis G virus replication.
    Manzano M
    Rev Esp Enferm Dig; 2002 Nov; 94(11):653-8. PubMed ID: 12690988
    [No Abstract]   [Full Text] [Related]  

  • 31. Detection of antihepatitis C virus antibody in severe Epstein-Barr virus-induced hepatitis.
    Banning AP; Brook MG; Bannister BA
    J Infect; 1991 May; 22(3):298-9. PubMed ID: 1649223
    [No Abstract]   [Full Text] [Related]  

  • 32. Cell culture and infection system for hepatitis C virus.
    Kato T; Date T; Murayama A; Morikawa K; Akazawa D; Wakita T
    Nat Protoc; 2006; 1(5):2334-9. PubMed ID: 17406476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Approaches to the development of novel inhibitors of hepatitis C virus replication.
    Clarke BE
    J Viral Hepat; 1995; 2(1):1-8. PubMed ID: 7493290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistence of HCV replication in non-A, non-B fulminant viral hepatitis.
    Yoshiba M; Sekiyama K; Sugata F; Okamoto H; Mayumi M
    Gastroenterol Jpn; 1991 Apr; 26(2):235. PubMed ID: 1645690
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of HCV replication by humanized-single domain transbodies to NS4B.
    Glab-Ampai K; Malik AA; Chulanetra M; Thanongsaksrikul J; Thueng-In K; Srimanote P; Tongtawe P; Chaicumpa W
    Biochem Biophys Res Commun; 2016 Aug; 476(4):654-664. PubMed ID: 27240954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The hepatitis C virus can be cultured in primary human hepatocytes, at last!].
    Rosenberg AR; Carpentier A; Podevin P
    Med Sci (Paris); 2010 Dec; 26(12):1012-4. PubMed ID: 21187030
    [No Abstract]   [Full Text] [Related]  

  • 37. Acquisition of susceptibility to hepatitis C virus replication in HepG2 cells by fusion with primary human hepatocytes: establishment of a quantitative assay for hepatitis C virus infectivity in a cell culture system.
    Ito T; Yasui K; Mukaigawa J; Katsume A; Kohara M; Mitamura K
    Hepatology; 2001 Sep; 34(3):566-72. PubMed ID: 11526543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C Virus-Induced Autophagy and Host Innate Immune Response.
    Chan ST; Ou JJ
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28805674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: a relevant ex vivo model of liver infection.
    Lagaye S; Shen H; Saunier B; Nascimbeni M; Gaston J; Bourdoncle P; Hannoun L; Massault PP; Vallet-Pichard A; Mallet V; Pol S
    Hepatology; 2012 Sep; 56(3):861-72. PubMed ID: 22454196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular models for the screening and development of anti-hepatitis C virus agents.
    Gondeau C; Pichard-Garcia L; Maurel P
    Pharmacol Ther; 2009 Oct; 124(1):1-22. PubMed ID: 19555718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.